CETUXIMAB REVERSE EGFR-TKI ACQUIRED -RESISTANCE IN NON-SMALL CELL LUNG CANCER IN VITRO AND IN VIVO THROUGH INHIBITING SURVIVAL

被引：0
|
作者：
Zhang, L. [1 ]
机构：
[1] Tongji Univ, Sch Med, Pulm Hosp, Dept Oncol, Shanghai 200092, Peoples R China
来源：
RESPIROLOGY | 2011年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：188 / 188
页数：1
相关论文
共 50 条
  • [1] Advances in the management of acquired resistance to EGFR-TKI in non-small cell lung cancer
    Fei Zhou
    Caicun Zhou
    Oncology and Translational Medicine, 2015, 1 (01) : 20 - 25
  • [2] REBIOPSY IN NON-SMALL CELL LUNG CANCER PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKI
    Yamauchi, Hiroyoshi
    Nakayama, Masayuki
    Yamamoto, Shinichi
    Saito, Tatsuya
    Okuyama, Akiko
    Mato, Naoko
    Yamasawa, Hideaki
    Suzuki, Takuji
    Bando, Masashi
    Hagiwara, Koichi
    RESPIROLOGY, 2017, 22 : 242 - 242
  • [3] Apatinib combined with EGFR-TKI in treating advanced non-small cell lung cancer with EGFR-TKI resistance
    Tian, R.
    Guo, W.
    Guo, Y.
    Zhang, X.
    Zhu, H.
    Shen, F.
    Xu, J.
    Zhang, X.
    Wang, R.
    Ren, X.
    Li, J.
    Song, X.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] Inhitibing GRP78 in non-small cell lung cancer with acquired resistance to EGFR-TKI
    Park, Jaewoo
    Purushothaman, Baskaran
    Hong, Sera
    Choi, Munkyung
    Song, Joon Myong
    Kang, Keon Wook
    CANCER RESEARCH, 2023, 83 (07)
  • [5] NOTCH-1 CONTRIBUTES TO EGFR-TKI ACQUIRED RESISTANCE IN NON-SMALL CELL LUNG CANCER
    Xie, M.
    Zhang, L.
    Xu, F.
    RESPIROLOGY, 2012, 17 : 89 - 89
  • [6] Acquired resistance of non-small cell lung cancer to EGFR-TKI: Role of AKT3.
    Huang, Shih-Hsiang
    Shih, Jin-Yuan
    Chen, Ching-Chow
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 55 - 56
  • [7] EGFR-TKI rechallenged treatment combined with apatinib in non-small cell lung cancer with EGFR-TKI resistance.
    Liang, Li
    Li, Fang
    Cao, Baoshan
    Zhang, Zhaohui
    Zhu, Xiang
    Wang, Jiadong
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Efficacy and safety of apatinib plus EGFR-TKI in advanced non-small cell lung cancer with EGFR-TKI resistance
    Tian, R.
    ANNALS OF ONCOLOGY, 2021, 32 : S980 - S981
  • [9] Propensity Score-Adjusted Survival Analysis of Non-Small Cell Lung Cancer Patients with Acquired Resistance to EGFR-TKI
    Watanabe, S.
    Takeda, Y.
    Kawamoto, H.
    Fujimoto, S.
    Naka, G.
    Sugiyama, H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2139 - S2139
  • [10] MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
    Li, Bing
    Ren, Shengxiang
    Li, Xuefei
    Wang, Yongsheng
    Garfield, David
    Zhou, Songwen
    Chen, Xiaoxia
    Su, Chunxia
    Chen, Mo
    Kuang, Peng
    Gao, Guanghui
    He, Yayi
    Fan, Lihong
    Fei, Ke
    Zhou, Caicun
    Schmit-Bindert, Gerald
    LUNG CANCER, 2014, 83 (02) : 146 - 153
12345